Active, Not Recruiting
A Study to Assess the Efficacy and Safety of Zipalertinib Versus Placebo for Adjuvant Treatment in Participants With Stage IB-IIIA NSCLC With Uncommon EGFR Mutations, Following Complete Tumor Resection
NCT07128199
- Conditions
- Adjuvant, Bronchial Neoplasms, Carcinoma, Bronchogenic, +15 more
- Locations
-
- Alaska Oncology and Hematology Anchorage, Alaska, United States
- City of Hope Comprehensive Cancer Center - Duarte Duarte, California, United States
- City of Hope Comprehensive Cancer Center Orange County Lennar Foundation Cancer Center Irvine, California, United States
- Scripps Clinic Torrey Pines La Jolla, California, United States